Reference health
Symptom‐relieving and neuroprotective effects of the phytocannabinoid Δ<sup>9</sup>‐THCV in animal models of Parkinson's disease
37/37 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
The 37 checked references that resolve
resolves10.1111/j.1460-9568.2008.06551.x
Endocannabinoid‐dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity
resolves10.1016/j.expneurol.2007.10.012
Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice
resolves10.1111/j.1476-5381.2010.00756.x
The plant cannabinoid Δ<sup>9</sup>‐tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice
resolves10.1016/S0014-2999(00)00211-9
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
resolves10.1096/fasebj.14.10.1432
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
resolves10.1038/sj.npp.1300407
Experimental Parkinsonism Alters Anandamide Precursor Synthesis, and Functional Deficits are Improved by AM404: A Modulator of Endocannabinoid Function
resolves10.1016/j.nbd.2004.10.015
Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism
resolves10.1046/j.1460-9568.2003.02896.x
Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa‐induced dyskinesias
resolves10.1016/j.brainres.2006.11.063
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties
resolves10.1016/j.neulet.2008.04.041
Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats
resolves10.1016/j.brainres.2005.12.014
Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease
resolves10.1523/JNEUROSCI.22-16-06900.2002
Experimental Parkinsonism Alters Endocannabinoid Degradation: Implications for Striatal Glutamatergic Transmission
resolves10.1002/jnr.22012
Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice
resolves10.1016/j.neures.2008.04.011
The cannabinoid CP55,940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: Implications in Parkinson's disease
resolves10.1016/j.bbr.2009.04.035
The CB1 antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease
resolves10.1046/j.0953-816x.2001.01812.x
Increased cannabinoid CB<sub>1</sub> receptor binding and activation of GTP‐binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP‐treated marmosets
resolves10.1016/j.nbd.2004.11.009
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
resolves10.1111/j.1471-4159.1993.tb09807.x
Dopaminergic Regulation of Cannabinoid Receptor mRNA Levels in the Rat Caudate‐Plitamen: An In Situ Hybridization Study
resolves10.1016/0014-2999(96)00326-3
Activation of the cannabinoid receptor by Δ9-tetrahydrocannabinol reduces γ-aminobutyric acid uptake in the globus pallidus
resolves10.1097/00002826-200405000-00003
Neurokinin B, Neurotensin, and Cannabinoid Receptor Antagonists and Parkinson Disease
resolves10.1007/978-3-211-73574-9_14
Biochemistry of postmortem brains in Parkinson’s disease: historical overview and future prospects
resolves10.1007/s00726-006-0317-y
An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats
resolves10.1126/science.283.5400.401
Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB
<sub>1</sub>
Receptor Knockout Mice
resolves10.1016/j.neurobiolaging.2009.03.017
Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors
resolves10.1038/sj.bjp.0707124
The psychoactive plant cannabinoid, Δ<sup>9</sup>‐tetrahydrocannabinol, is antagonized by Δ<sup>8</sup>‐ and Δ<sup>9</sup>‐tetrahydrocannabivarin in mice<i>in vivo</i>
resolves10.1002/ana.20462
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients
resolves10.1111/j.1460-9568.2009.06764.x
WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease
resolves10.1016/S0166-4328(01)00168-1
Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease
resolves10.1016/S0024-3205(99)00618-9
Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen
resolves10.1016/S0024-3205(99)00293-3
Motor actions of cannabinoids in the basal ganglia output nuclei
resolves10.1002/mds.10312
Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high‐dose levodopa in the reserpine‐treated rat model of Parkinson's disease
resolves10.1038/sj.bjp.0706414
Evidence that the plant cannabinoid Δ<sup>9</sup>‐tetrahydrocannabivarin is a cannabinoid CB<sub>1</sub>and CB<sub>2</sub>receptor antagonist
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1111/j.1476-5381.2011.01278.x"><img src="https://citestamp.com/citestamped/10.1111/j.1476-5381.2011.01278.x/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1111/j.1476-5381.2011.01278.x)